Brez internetne povezave — prikazana je shranjena različica strani.

enGene Therapeuti…

CACAD
← Na Filter Delnic

enGene Therapeutics Inc. (US:ENGN) — Biotechnology: Biological Products (No Diagnostic Substances). Število borz, na katerih se trgujejo delnice družbe: 1. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O Podjetju

Spletna Stran
engene.com
Sektor
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Sedež
SAINT-LAURENT, Canada
Izvršni Direktor
Ronald H. W. Cooper
Zaposleni
81
Delnice v Obtoku
67.02 mio. na dan 2026-09-02
Prosto Prenosljive Delnice
32.75 mio.
Tržna Kapitalizacija
132.02 mio. USD
Notranje Osebe
0.11%
Institucionalni Vlagatelji
84.11%
Panoga (SIC)
Biological Products, (No Diagnostic Substances)
P/E
izguba
FCF
−104 mio. USD
Dolg
25.2 mio. USD
neto denar
Dobiček in FCF — za 12 mesecev do 31.07.2026 (najnovejše poročilo podjetja).
NAV
3.44 USD · P/NAV 0.45
Balance sheet date31.07.2026
Assets288 mio. USD
− Liabilities58.0 mio. USD
= NAV (lastniški delež delničarjev podjetja)230 mio. USD
= Tangible NAV230 mio. USD
Delnice67 014 067
NAV per share3.44 USD
Otipljiv NAV na Delnico3.44 USD
Share price (ENGN)1.5600 USD
P/NAV0.45
NAV history
Balance sheet dateNAVNAV per share
31.07.2026230 mio. USD3.44 USD
30.04.2026255 mio. USD3.81 USD
31.01.2026282 mio. USD4.20 USD
31.10.2025168 mio. USD3.22 USD
31.07.2025201 mio. USD3.93 USD
30.04.2025227 mio. USD4.45 USD
31.01.2025250 mio. USD4.90 USD
31.10.2024273 mio. USD5.35 USD
Opis

enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known as enGene Holdings Inc. and changed its name to enGene Therapeutics Inc. in April 2026. enGene Therapeutics Inc. is based in Montreal, Canada.

oglas

Borze in Oznake

BorzaOznakaValutaCenaVrsta
US USA StocksENGNUSD1.56 -4.29%navadne delnice

Cena v 3 Mesecih

US:ENGN · USD
dan rasti dan padcaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Največji Imetniki

ImetnikDeležDelniceDatum Poročila
FCPM III Services B.V.14.37%9.63 mio.2026-06-30
BML Capital Management,…9.95%6.67 mio.2026-06-30
Siren, L.L.C.9.34%6.26 mio.2026-06-30
Perceptive Advisors Llc7.2%4.82 mio.2026-06-30
Ameriprise Financial, In…3.99%2.68 mio.2026-06-30
Nextech Invest, Ltd.3.47%2.32 mio.2026-06-30
Adar1 Capital Management…3.14%2.1 mio.2026-06-30
Vestal Point Capital, LP2.49%1.67 mio.2026-06-30
Acorn Capital Advisors,…1.9%1.27 mio.2026-06-30
Peapod Lane Capital LLC1.64%1.1 mio.2026-06-30
Franklin Strategic Serie…0.73%486 5792026-04-30
Fidelity Concord Street…0.05%34 9822026-07-31
ETFis Series Trust I-Vir…0.05%32 6252026-04-30
TIFF INVESTMENT PROGRAM-…0.02%10 6392026-06-30
JNL Series Trust-JNL/DFA…0.01%9 9742026-06-30
Exchange Place Advisors…0.01%7 6492026-06-30
GROSSMAN WILLIAM (Office…≈0.01%5 1022026-09-22
Advanced Series Trust-AS…0%1 3762026-06-30
FORBION GROWTH OPPORTUNI…——2024-10-30